{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:16:22Z","timestamp":1790039782991,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10096-017-2931-x","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T14:17:16Z","timestamp":1487254636000},"page":"1065-1071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Drug-resistant Neisseria gonorrhoeae: latest developments"],"prefix":"10.1007","volume":"36","author":[{"given":"B.","family":"Suay-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"P\u00e9rez-Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"2931_CR1","unstructured":"World Health Organization (WHO), Department of Reproductive Health and Research (2012) Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 36 pp"},{"key":"2931_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJMp1112456","volume":"366","author":"GA Bolan","year":"2012","unstructured":"Bolan GA, Sparling PF, Wasserheit JN (2012) The emerging threat of untreatable gonococcal infection. N Eng J Med 366:485\u2013487. doi: 10.1056\/NEJMp1112456","journal-title":"N Eng J Med"},{"key":"2931_CR3","unstructured":"Centers for Disease Control and Prevention (CDC) (2012) Cephalosporin-resistant Neisseria gonorrhoeae public health response plan. 43 pp"},{"issue":"3","key":"2931_CR4","first-page":"22","volume":"33","author":"IN Bodoev","year":"2015","unstructured":"Bodoev IN, Il\u2019ina EN (2015) Molecular mechanisms of drug resistance Neisseria gonorrhoeae: history and prospects. Mol Gen Mikrobiol Virusol 33(3):22\u201327","journal-title":"Mol Gen Mikrobiol Virusol"},{"key":"2931_CR5","doi-asserted-by":"publisher","unstructured":"Unemo M, del Rio C, Shafer WM (2016) Antimicrobial resistance expressed by Neisseria. gonorrhoeae: a major global public health problem in the 21st century. Microbiol Spectr 4(3). doi: 10.1128\/microbiolspec.EI10-0009-2015","DOI":"10.1128\/microbiolspec.EI10-0009-2015"},{"issue":"16","key":"2931_CR6","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1128\/jb.177.16.4669-4675.1995","volume":"177","author":"C Fermer","year":"1995","unstructured":"Fermer C, Kristiansen BE, Sk\u00f6ld O et al (1995) Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species. J Bacteriol 177(16):4669\u20134675","journal-title":"J Bacteriol"},{"key":"2931_CR7","unstructured":"Tribuddharat C, Pongpech P, Charoenwatanachokchai A et al (2016) Gonococcal antimicrobial susceptibility and prevalence of bla TEM-1, bla TEM-135 genes in Thailand. Jpn J Infect Dis"},{"key":"2931_CR8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/AAC.46.3.769-777.2002","volume":"46","author":"PA Ropp","year":"2002","unstructured":"Ropp PA, Hu M, Olesky M et al (2002) Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 46:769\u2013777","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"2931_CR9","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1128\/AAC.01568-16","volume":"60","author":"C Curraize de","year":"2016","unstructured":"de Curraize C, Kumanski S, Mica\u00eblo M et al (2016) Ceftriaxone-resistant Neisseria gonorrhoeae isolates (2010 to 2014) in France characterized by using whole-genome sequencing. Antimicrob Agents Chemother 60(11):6962\u20136964. doi: 10.1128\/AAC.01568-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2931_CR10","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s10096-016-2696-7","volume":"35","author":"J Serra-Pladevall","year":"2016","unstructured":"Serra-Pladevall J, Barber\u00e1 MJ, Rodriguez S et al (2016) Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins. Eur J Clin Microbiol Infect Dis 35(9):1549\u20131556. doi: 10.1007\/s10096-016-2696-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2931_CR11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/AAC.30.5.664","volume":"30","author":"SA Morse","year":"1986","unstructured":"Morse SA, Johnson SR, Biddle JW et al (1986) High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother 30:664\u2013670","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(76)92466-1","volume":"2","author":"I Phillips","year":"1976","unstructured":"Phillips I (1976) Beta-lactamase-producing, penicillin-resistant gonococcus. Lancet 2:656\u2013657","journal-title":"Lancet"},{"key":"2931_CR13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmbi.1998.1780","volume":"279","author":"C Davies","year":"1998","unstructured":"Davies C, Bussiere DE, Golden BL et al (1998) Ribosomal proteins S5 and L6: high-resolution crystal structures and roles in protein synthesis and antibiotic resistance. J Mol Biol 279:873\u2013888","journal-title":"J Mol Biol"},{"key":"2931_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fmicb.2013.00186","volume":"4","author":"EN Ilina","year":"2013","unstructured":"Ilina EN, Malakhova MV, Bodoev IN et al (2013) Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae. Front Microbiol 4:186. doi: 10.3389\/fmicb.2013.00186","journal-title":"Front Microbiol"},{"key":"2931_CR15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2958.1994.tb01297.x","volume":"14","author":"RJ Belland","year":"1994","unstructured":"Belland RJ, Morrison SG, Ison C et al (1994) Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 14:371\u2013380","journal-title":"Mol Microbiol"},{"key":"2931_CR16","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/infdis\/jis277","volume":"205","author":"AN Kunz","year":"2012","unstructured":"Kunz AN, Begum AA, Wu H et al (2012) Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations. J Infect Dis 205:1821\u20131829. doi: 10.1093\/infdis\/jis277","journal-title":"J Infect Dis"},{"key":"2931_CR17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.43.6.1367","volume":"43","author":"MC Roberts","year":"1999","unstructured":"Roberts MC, Chung WO, Roe D et al (1999) Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother 43:1367\u20131372","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1128\/JB.01165-08","volume":"191","author":"JP Folster","year":"2009","unstructured":"Folster JP, Johnson PJ, Jackson L et al (2009) MtrR modulates rpoH expression and levels of antimicrobial resistance in Neisseria gonorrhoeae. J Bacteriol 191:287\u2013297. doi: 10.1128\/JB.01165-08","journal-title":"J Bacteriol"},{"key":"2931_CR19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/AAC.30.5.664","volume":"30","author":"SA Morse","year":"1986","unstructured":"Morse SA, Johnson SR, Biddle JW et al (1986) High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother 30:664\u2013670","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM (2014) Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 27:587\u2013613. doi: 10.1128\/CMR.00010-14","journal-title":"Clin Microbiol Rev"},{"key":"2931_CR21","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K et al (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55:3538\u20133545. doi: 10.1128\/AAC.00325-11","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R et al (2012) High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56:1273\u20131280. doi: 10.1128\/AAC.05760-11","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR23","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1056\/NEJMc1408109","volume":"371","author":"MM Lahra","year":"2014","unstructured":"Lahra MM, Ryder N, Whiley DM (2014) A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Eng J Med 371:1850\u20131851. doi: 10.1056\/NEJMc1408109","journal-title":"N Eng J Med"},{"issue":"7","key":"2931_CR24","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1128\/AAC.00504-16","volume":"60","author":"S Nakayama","year":"2016","unstructured":"Nakayama S, Shimuta K, Furubayashi K et al (2016) New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother 60(7):4339\u20134341. doi: 10.1128\/AAC.00504-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2931_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3201\/eid2201.151247","volume":"22","author":"I Martin","year":"2016","unstructured":"Martin I, Sawatzky P, Liu G et al (2016) Decline in decreased cephalosporin susceptibility and increase in azithromycin resistance in Neisseria gonorrhoeae, Canada. Emerg Infect Dis 22(1):65\u201367. doi: 10.3201\/eid2201.151247","journal-title":"Emerg Infect Dis"},{"issue":"35","key":"2931_CR26","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMc1512757","volume":"734","author":"H Fifer","year":"2016","unstructured":"Fifer H, Natarajan U, Jones L et al (2016) Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med 734(35):2504\u20132506. doi: 10.1056\/NEJMc1512757","journal-title":"N Engl J Med"},{"key":"2931_CR27","unstructured":"World Health Organization (WHO) (2012) Strategies and laboratory methods for strengthening surveillance of sexually transmitted infections. Available online at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/75729\/1\/9789241504478_eng.pdf"},{"key":"2931_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","volume":"15","author":"M Unemo","year":"2015","unstructured":"Unemo M (2015) Current and future antimicrobial treatment of gonorrhoea\u2014the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 15:364. doi: 10.1186\/s12879-015-1029-2","journal-title":"BMC Infect Dis"},{"issue":"Suppl 1","key":"2931_CR29","first-page":"52","volume":"22","author":"Japanese Society of Sexually Transmitted Infection","year":"2011","unstructured":"Japanese Society of Sexually Transmitted Infection (2011) Gonococcal infection. Sexually transmitted infections, diagnosis and treatment guidelines 2011. Jpn Sex Transm Dis 22(Suppl 1):52\u201359","journal-title":"Jpn Sex Transm Dis"},{"key":"2931_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA (2015) Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64:1\u2013137","journal-title":"MMWR Recomm Rep"},{"key":"2931_CR31","unstructured":"Public Health Agency of Canada (2013) Canadian guidelines on sexually transmitted infections. Gonococcal infections chapter. Available online at: http:\/\/www.phac-aspc.gc.ca\/std-mts\/sti-its\/cgsti-ldcits\/assets\/pdf\/section-5-6-eng.pdf"},{"key":"2931_CR32","unstructured":"Australasian Sexual Health Alliance (ASHA) (2016) Australian STI management guidelines for use in primary care. Available online at: http:\/\/www.sti.guidelines.org.au\/sexually-transmissible-infections\/gonorrhoea#management"},{"key":"2931_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M (2013) 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 24:85\u201392. doi: 10.1177\/0956462412472837","journal-title":"Int J STD AIDS"},{"key":"2931_CR34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/cid\/ciu521","volume":"59","author":"RD Kirkcaldy","year":"2014","unstructured":"Kirkcaldy RD, Weinstock HS, Moore PC et al (2014) The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Clin Infect Dis 59:1083\u20131091. doi: 10.1093\/cid\/ciu521","journal-title":"Clin Infect Dis"},{"key":"2931_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.diagmicrobio.2012.06.006","volume":"74","author":"DJ Biedenbach","year":"2012","unstructured":"Biedenbach DJ, Turner LL, Jones RN et al (2012) Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains. Diagn Microbiol Infect Dis 74:204\u2013206. doi: 10.1016\/j.diagmicrobio.2012.06.006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2931_CR36","unstructured":"Roberts MC, Remy JM, Longcor JD et al (2013) In vitro activity of delafloxacin against Neisseria gonorrhoeae clinical isolates. In: Proceedings of the STI & AIDS World Congress, Vienna, Austria, July 2013"},{"key":"2931_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jiac.2015.01.010","volume":"21","author":"R Hamasuna","year":"2015","unstructured":"Hamasuna R, Yasuda M, Ishikawa K et al (2015) The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012\u20132013. J Infect Chemother 21:340\u2013345. doi: 10.1016\/j.jiac.2015.01.010","journal-title":"J Infect Chemother"},{"key":"2931_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ijantimicag.2014.07.017","volume":"44","author":"D Kazamori","year":"2014","unstructured":"Kazamori D, Aoi H, Sugimoto K et al (2014) In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens. Int J Antimicrob Agents 44:443\u2013449. doi: 10.1016\/j.ijantimicag.2014.07.017","journal-title":"Int J Antimicrob Agents"},{"key":"2931_CR39","unstructured":"Kerstein K, Fyfe C, Sutcliffe JA et al (2013) Eravacycline (TP-434) is active against susceptible and multidrug-resistant Neisseria gonorrhoeae. In: Proceedings of the 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Denver, Colorado, USA, 10\u201313 September 2013. Poster E-1181"},{"key":"2931_CR40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.diagmicrobio.2004.08.007","volume":"50","author":"YY Zhang","year":"2004","unstructured":"Zhang YY, Zhou L, Zhu DM et al (2004) In vitro activities of tigecycline against clinical isolates from Shanghai, China. Diagn Microbiol Infect Dis 50:267\u2013281","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2931_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/AAC.01051-12","volume":"57","author":"K Fujimoto","year":"2013","unstructured":"Fujimoto K, Takemoto K, Hatano K et al (2013) Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals. Antimicrob Agents Chemother 57:697\u2013707. doi: 10.1128\/AAC.01051-12","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/jac\/dku344","volume":"70","author":"S Jacobsson","year":"2015","unstructured":"Jacobsson S, Golparian D, Phan LT et al (2015) In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains. J Antimicrob Chemother 70:173\u2013177. doi: 10.1093\/jac\/dku344","journal-title":"J Antimicrob Chemother"},{"key":"2931_CR43","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/AAC.00036-12","volume":"56","author":"D Golparian","year":"2012","unstructured":"Golparian D, Fernandes P, Ohnishi M et al (2012) In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob Agents Chemother 56:2739\u20132742. doi: 10.1128\/AAC.00036-12","journal-title":"Antimicrob Agents Chemother"},{"key":"2931_CR44","unstructured":"Koeth LM, Difranco-Fisher J (2013) In vitro activity of dalbavancin against Neisseria gonorrhoeae and development of a broth microdilution method. In: Proceedings of IDWeek 2013, San Francisco, California, USA, 2\u20136 October 2013. Poster 255"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-2931-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2931-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2931-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:33:34Z","timestamp":1568835214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-2931-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-2931-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}